Ophthalmology

Complications & Warning Signs: Detachment and IRU

At a Glance

After CMV retinitis, retinal scars can tear and cause retinal detachment, while immune recovery can trigger inflammation called IRU. A curtain, sudden floaters, or new vision loss needs same-day emergency eye assessment; treatment decisions require an ophthalmologist.

Even after the CMV virus is under control, the journey toward protecting your sight continues. Two major complications can occur as the eye heals: retinal detachment caused by structural damage, and Immune Recovery Uveitis (IRU), a paradoxical reaction that happens as your immune system gets stronger ^[1]^[2].

Rhegmatogenous Retinal Detachment (RRD)

When CMV retinitis infects the retina, it causes necrosis (tissue death). As the infection heals, it leaves behind thin, fragile scars that are prone to developing holes or tears ^[3]^[1]. If fluid from the center of the eye seeps through these tears, it can peel the retina away from the back of the eye—a condition called rhegmatogenous retinal detachment ^[1]^[4].

Who is at risk?: Risk is higher if you had a large area of infection, or if the infection was near the center of your eye (Zone 1) ^[5]^[6].
The Treatment: This is a surgical emergency. The standard repair is a vitrectomy, where a surgeon removes the fluid inside the eye, repairs the tears with a laser, and uses a bubble of gas or silicone oil to hold the retina in place while it heals ^[7]^[8]. Warning: If a gas bubble is used, you absolutely cannot travel by air, go to high altitudes, or receive nitrous oxide anesthesia until the surgeon confirms it is safe, as the pressure change can cause excruciating pain and blindness.
Recovery: Anatomic success rates for reattaching the retina are high (over 80-90% in some studies), but your final vision often depends on whether the detachment reached the macula (the center of your vision) and how quickly the surgery was performed; vision may remain limited despite successful reattachment ^[7]^[8]^[9]. A curtain or expanding field defect requires same-day assessment.

Immune Recovery Uveitis (IRU)

Ironically, as your immune system recovers—which is the goal of your treatment—it can sometimes cause new problems. Immune Recovery Uveitis (IRU) occurs when your newly strengthened immune system “recognizes” leftover pieces of the CMV virus in your eye and launches an inflammatory attack ^[2]^[10].

This typically happens weeks or months after starting HIV medications (ART) or after your transplant begins to “take” ^[11]^[12]. In HIV patients, this often occurs once the CD4 count rises above 100 cells/µL ^[12].

Is it IRU or a CMV Relapse?
Distinguishing between the two is vital. Note: The following table lists clinical clues, but they are not diagnostic rules. Relapse can occur despite CD4 recovery or during immune recovery and may produce inflammation. Only an ophthalmologist using serial examinations, imaging, or intraocular testing can make the distinction. Never start, stop, or increase steroid drops or antivirals on your own.

Feature (Clinical Clues)	Immune Recovery Uveitis (IRU)	CMV Relapse (Active Virus)
Immune Status	Improving (High/Rising CD4)	Weak (Low CD4 < 50)
Retina Appearance	Healed scars; no new white spots	New white, “granular” spots ^[13]
Inflammation	Significant (haze, redness)	Minimal to none ^[14]
Main Threat	Swelling (edema) and cataracts	Tissue death (necrosis) ^[15]

Long-Term Threats from IRU

If the inflammation from IRU is not managed, it can lead to several vision-threatening issues:

Cystoid Macular Edema (CME): Swelling in the center of the retina that makes vision blurry or distorted ^[16]^[17].
Cataracts: A clouding of the eye’s natural lens, which can happen more quickly in eyes with chronic inflammation ^[12]^[18].
Glaucoma: High pressure inside the eye that can damage the optic nerve ^[12].

Treatment for IRU may include topical, periocular, intravitreal, or systemic corticosteroids and other targeted treatments selected by an ophthalmologist, but active CMV must first be excluded or covered with appropriate antiviral therapy, and intraocular pressure must be monitored ^[19].

The macula (for central, sharp vision) and the optic nerve (the cable to the brain) are the two most critical parts of your eye. If CMV or the inflammation from IRU reaches these areas, the risk of permanent, severe vision loss increases significantly ^[20]^[21]. Your doctor may use Optical Coherence Tomography (OCT)—a high-tech scan—to monitor these areas for early signs of swelling or damage ^[3]^[19].

If you notice a sudden change in your central vision or a “curtain” falling over your sight, seek emergency care immediately ^[22]^[1]. Early intervention is the key to preventing the most serious complications of this disease ^[5]^[23].

Common questions in this guide

What are the warning signs of retinal detachment after CMV retinitis?

A sudden shower of floaters, a growing shadow or curtain, or an expanding area of missing vision can signal retinal detachment. Seek same-day emergency eye assessment rather than waiting for a routine appointment.

Why can retinal detachment happen after CMV retinitis heals?

CMV retinitis can cause tissue death in the retina. As the infection heals, thin, fragile scars may develop holes or tears that allow fluid to move beneath the retina and pull it away from the back of the eye.

What is immune recovery uveitis, and when can it occur?

Immune recovery uveitis, or IRU, is inflammation that occurs when a recovering immune system reacts to leftover CMV material in the eye. It may develop weeks or months after HIV treatment begins or after a transplant starts functioning, and in people with HIV it often occurs as the CD4 count rises above 100 cells per microliter.

How do doctors distinguish IRU from a CMV relapse?

Doctors consider immune status, retinal appearance, and the amount of inflammation, but no single clinical clue proves the diagnosis. An ophthalmologist may use repeated eye examinations, imaging such as optical coherence tomography, and sometimes testing inside the eye; a CMV relapse can still occur during immune recovery. Do not start, stop, or change steroid drops or antiviral medicines without medical guidance.

How is retinal detachment treated after CMV retinitis?

Retinal detachment is usually treated urgently with vitrectomy, during which the surgeon repairs retinal tears with laser and uses a gas bubble or silicone oil to support the retina. If gas is used, air travel, high altitudes, and nitrous oxide anesthesia are unsafe until the surgeon confirms that the bubble is gone or travel is safe.

What problems can IRU cause if it is not controlled?

Inflammation from IRU can cause cystoid macular edema, which may blur or distort central vision, as well as cataracts and glaucoma. An ophthalmologist may use corticosteroid treatment or other targeted therapy after active CMV has been excluded or appropriately covered with antiviral treatment, while monitoring eye pressure.

Curated prompts to bring to your next appointment.

1.Do I have any signs of a retinal tear or thinning in the areas where my retinitis has healed?
2.Since my immune system is getting stronger, are you seeing any signs of 'immune recovery uveitis' (IRU)?
3.How can you tell the difference between new inflammation from IRU and a return of the actual CMV virus?
4.If I develop macular edema (swelling), what are the safest ways to treat the inflammation without making the CMV come back?
5.Is my retina 'stable' enough that the risk of a detachment is decreasing, or do I still need frequent monitoring?
6.If I need surgery for a detachment, will you use silicone oil or gas, and how will that affect my vision?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Healing CMV retinitis can leave thin retinal scars that develop tears and cause retinal detachment, especially after extensive or Zone 1 infection.
A curtain or shadow, expanding field defect, sudden shower of floaters, or abrupt central vision change requires same-day emergency eye assessment.
IRU occurs when a recovering immune system reacts to residual CMV after HIV treatment or transplantation and can lead to macular edema, cataracts, or glaucoma.
IRU and CMV relapse can overlap clinically, so an ophthalmologist may need serial examinations, imaging, and sometimes intraocular testing to distinguish them.
Retinal detachment repair commonly uses vitrectomy, laser, and gas or silicone oil; gas requires restrictions on air travel, high altitude, and nitrous oxide until cleared by the surgeon.

References (23)

1
Bilateral Cytomegalovirus Retinitis in a Patient with Systemic Lupus Erythematosus.
Haze M, Kobayashi T, Kakurai K, et al.
Case reports in ophthalmology 2016; (7(2)):303-8 doi:10.1159/000446391.
PMID: 27462259
2
Immune recovery uveitis: a focus review.
Rodrigues Alves N, Barão C, Mota C, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2024; (262(8)):2703-2712 doi:10.1007/s00417-024-06415-y.
PMID: 38381160
3
OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CYTOMEGALOVIRUS RETINITIS: A Longitudinal Study.
Invernizzi A, Agarwal A, Ravera V, et al.
Retina (Philadelphia, Pa.) 2018; (38(1)):108-117 doi:10.1097/IAE.0000000000001503.
PMID: 28145973
4
Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation.
Wang X, Lu Y, Li H, et al.
Journal of personalized medicine 2023; (13(4)) doi:10.3390/jpm13040639.
PMID: 37109025
5
Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation.
Zeng Q, Yao Y, Hou J, Miao H
Biomedicines 2025; (13(1)) doi:10.3390/biomedicines13010242.
PMID: 39857825
6
COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS.
Kim DY, Jo J, Joe SG, et al.
Retina (Philadelphia, Pa.) 2017; (37(2)):376-381 doi:10.1097/IAE.0000000000001144.
PMID: 28118285
7
Outcomes of 25-gauge pars plana vitrectomy for cytomegalovirus retinitis-related retinal detachment.
Moharana B, Dogra M, Tigari B, et al.
Indian journal of ophthalmology 2021; (69(9)):2361-2366 doi:10.4103/ijo.IJO_3539_20.
PMID: 34427223
8
Surgical outcomes and prognostic factors following vitrectomy in acquired immune deficiency syndrome patients with cytomegalovirus retinitis-related retinal detachment.
Sittivarakul W, Prapakornkovit V, Jirarattanasopa P, et al.
Medicine 2020; (99(43)):e22889 doi:10.1097/MD.0000000000022889.
PMID: 33120835
9
Prognostic Factors for Outcome after Vitrectomy for Retinal Detachment Secondary to Cytomegalovirus Retinitis in Patients with AIDS: A Retrospective Single-center Analysis.
Kong W, Tao Y, Xie L, et al.
Ocular immunology and inflammation 2021; (29(7-8)):1547-1552 doi:10.1080/09273948.2020.1764591.
PMID: 32634031
10
Cytomegalovirus retinitis and immune recovery uveitis in a pediatric patient with leukemia.
Yavuz Saricay L, Baldwin G, Leake K, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2023; (27(1)):52-55 doi:10.1016/j.jaapos.2022.10.004.
PMID: 36521818
11
Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell.
Kim JH, Cho MH, Ban JH, et al.
Korean journal of ophthalmology : KJO 2025; (39(1)):71-79 doi:10.3341/kjo.2024.0133.
PMID: 39828283
12
Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore.
Yeo TH, Yeo TK, Wong EP, et al.
Journal of ophthalmic inflammation and infection 2016; (6(1)):41 doi:10.1186/s12348-016-0110-3.
PMID: 27822743
13
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.
Jabs DA, Van Natta ML, Holland GN, et al.
American journal of ophthalmology 2017; (174()):23-32 doi:10.1016/j.ajo.2016.10.011.
PMID: 27984023
14
Cytomegalovirus retinitis in hospitalized people living with HIV in the late antiretroviral therapy era in São Paulo, Brazil.
Bogoni G, Lucas Júnior RM, Reis Schneider GA, et al.
International journal of STD & AIDS 2023; (34(1)):48-53 doi:10.1177/09564624221135294.
PMID: 36259434
15
Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment.
Zhang J, Kamoi K, Zong Y, et al.
Viruses 2024; (16(9)) doi:10.3390/v16091427.
PMID: 39339903
16
Risk Factors for Immune Recovery Uveitis in Patients with Cytomegalovirus Retinitis After Hematopoietic Stem Cell Transplantation.
Kim JY, Park YG, Lee DG, Park YH
Ocular immunology and inflammation 2026; (34(4)):723-730 doi:10.1080/09273948.2026.2620452.
PMID: 41996150
17
Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Immune Recovery Uveitis.
Koc H, Bayram U
Ocular immunology and inflammation 2025; (33(7)):1495-1500 doi:10.1080/09273948.2025.2496977.
PMID: 40265289
18
Analysis and Outcomes of Cataract Surgery in Patients with Acquired Immunodeficiency Syndrome.
Chew GWM, Teoh SCB, Agrawal R
Ocular immunology and inflammation 2017; (25(4)):535-539 doi:10.3109/09273948.2016.1158281.
PMID: 27082491
19
Diffuse retinal dysfunction following immune reconstitution uveitis in patients with prior cytomegalovirus retinitis: a novel observation.
Yuen YS, Holder GE, Lingam G, Shen TYT
Documenta ophthalmologica. Advances in ophthalmology 2023; (147(2)):139-145 doi:10.1007/s10633-023-09947-6.
PMID: 37639171
20
Atypical cytomegalovirus retinitis in non-Hodgkin's lymphoma.
Tyagi M, Ambiya V, Mathai A, Narayanan R
BMJ case reports 2015; (2015()).
PMID: 26240105
21
Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis.
Iu LP, Fan MC, Lau JK, et al.
American journal of ophthalmology 2016; (165()):145-53.
PMID: 27005706
22
Cytomegalovirus Retinitis Complicated With Rhegmatogenous Retinal Detachment in a Non-HIV Patient With Pure Red Cell Aplasia.
Tan CM, Noram MS
Cureus 2025; (17(9)):e92998 doi:10.7759/cureus.92998.
PMID: 41141209
23
Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era.
Singh SR, Dogra M, Kaur S, et al.
Ocular immunology and inflammation 2020; (28(1)):119-125 doi:10.1080/09273948.2018.1538460.
PMID: 30395753

This page is for informational purposes only and does not constitute medical advice. It explains complications after CMV retinitis but cannot assess your eye; sudden vision changes or a curtain over your vision require urgent ophthalmic evaluation.

Get notified when new evidence is published on Cytomegalovirus retinitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents